SCHEMBL6132086

SCHEMBL6132086

CSc1nccc(-c2cn[nH]c2-c2ccccc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 4/20 0.50
RPS6KA3 P51812 3/20 0.50
MAPK14 Q16539 3/20 0.50
CDK2 P24941 2/20 0.50
AURKA O14965 1/20 0.50
CDK1 P06493 1/20 0.50
LYN P07948 1/20 0.50
PIM1 P11309 1/20 0.50
FGFR1 P11362 1/20 0.50
PRKACA P17612 1/20 0.50
RPS6KB1 P23443 1/20 0.50
MARK3 P27448 1/20 0.50
AKT1 P31749 1/20 0.50
GSK3B P49841 1/20 0.50
PRKCZ Q05513 1/20 0.50
PRKCD Q05655 1/20 0.50
ERBB4 Q15303 1/20 0.50
CDC42BPA Q5VT25 1/20 0.50
MARK2 Q7KZI7 1/20 0.50
AKT3 Q9Y243 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6070097 0.90 TGFBR1 (0.60) TGFBR1RPS6KA3MAPK14CDK2AURKA
SCHEMBL2965363 0.81 LMNA (0.47) TGFBR1MAPK14CDK2CDK1MAPK10
SCHEMBL1384932 0.80 ADORA2A (0.45) MAPK14CDK2AKT1KDM4ELMNA
SCHEMBL1034731 0.78 DUSP10 (0.54) MAPK14AURKAPRKACAKDM4EALDH1A1
SCHEMBL5726072 0.78 TGFBR1 (0.48) TGFBR1RPS6KA3MAPK14CDK2AURKA
SCHEMBL2963770 0.78 LMNA (0.47) TGFBR1MAPK14CDK2CDK1MAPK10
SCHEMBL6069697 0.78 LMNA (0.40) TGFBR1MAPK14CDK2MAPK10MAPK8
SCHEMBL2959107 0.76 CYP2C19 (0.43) MAPK14LMNAL3MBTL1MAPK13MAPK12
SCHEMBL5726564 0.75 MAPK1 (0.54) RPS6KA3MAPK14CDK2AURKAPRKACA
SCHEMBL6987464 0.73 KDM4E (0.54) MAPK14CDK2MAPK9KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP claimed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP claimed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO claimed